PDL BioPharma (United States)

PDL BioPharma (United States)

PDL BioPharma is a publicly traded American holding company that since 2008 manages patents and other intellectual property that had been generated by the company. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for PDL BioPharma (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

43%


Total
Publications

251


Total Open
Publications

108


Total
Citations

25K


Open Access
Percentage

43%


Total
Publications

251


Total Open
Publications

108


Total
Citations

25K

Wikipedia

Website

download

Breakdown

19% 17% 7% 57%

Publisher Open

19%

Both

17%

Other Platform Open

7%

Closed

57%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

35

Hybrid 9%

8

No Guarantees 52%

46

Other Platform Open

Other Internet 57%

34

Domain 33%

20

Institution 13%

8

Preprint 7%

4

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

DOI
Other Internet
34
PubMed Central
Domain
20
bioRxiv
Preprint
3
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
2
Kanazawa University
Institution
2
University of Rome Tor Vergata
Institution
1
University of Geneva
Institution
1
Royal Netherlands Academy of Arts and Sciences
Institution
1
Research Square
Preprint
1
Office of Scientific and Technical Information
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share